Therapeutic Antibody

Product introduction:Protein stock solution. Each type of McAb is packed in a frozen storage tube, and its mass is 1MG or 5MG, and its volume is slightly different according to its concentration.Before use, it can be diluted according to its own

Product introduction:Protein stock solution. Each type of McAb is packed in a frozen storage tube, and its mass is 1MG or 5MG, and its volume is slightly different according to its concentration.Before use, it can be diluted according to its own

Product introduction:Protein stock solution. Each type of McAb is packed in a frozen storage tube, and its mass is 1MG or 5MG, and its volume is slightly different according to its concentration.Before use, it can be diluted according to its own

Product introduction:Protein stock solution. Each type of McAb is packed in a frozen storage tube, and its mass is 1MG or 5MG, and its volume is slightly different according to its concentration.Before use, it can be diluted according to its own

Product introduction:Protein stock solution. Each type of McAb is packed in a frozen storage tube, and its mass is 1MG or 5MG, and its volume is slightly different according to its concentration.Before use, it can be diluted according to its own

Cantuzumab is a monoclonal antibody that can binds the CanAg antigen. Cantuzumab is typically linked to one of several cytotoxic agents, yielding antibody-drug conjugates (ADC), such as Cantuzumab mertansine ( HY-P99492 ) and Cantuzumab ravtansine (

Cantuzumab is a monoclonal antibody that can binds the CanAg antigen. Cantuzumab is typically linked to one of several cytotoxic agents, yielding antibody-drug conjugates (ADC), such as Cantuzumab mertansine ( HY-P99492 ) and Cantuzumab ravtansine (

Cantuzumab is a monoclonal antibody that can binds the CanAg antigen. Cantuzumab is typically linked to one of several cytotoxic agents, yielding antibody-drug conjugates (ADC), such as Cantuzumab mertansine ( HY-P99492 ) and Cantuzumab ravtansine (

Gemtuzumab is a monoclonal antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). Gemtuzumab can be used for synthesis of antibody-drug conjugate (ADC) , Gemtuzumab ozogamicin ( HY-109539 ).

Gemtuzumab is a monoclonal antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). Gemtuzumab can be used for synthesis of antibody-drug conjugate (ADC) , Gemtuzumab ozogamicin ( HY-109539 ).

InformationRituximab (anti-CD20) Rituximab (anti-CD20) is a chimeric anti-CD20 mAb that binds the CD20 antigen on B cells with a binding affinity of 5 nM, MW: 143.86 KD.

InformationRituximab (anti-CD20) Rituximab (anti-CD20) is a chimeric anti-CD20 mAb that binds the CD20 antigen on B cells with a binding affinity of 5 nM, MW: 143.86 KD.